Browsing: openai

An ongoing conversation — both within and outside of the tech community — has been about just how and when…

Leaders at Mira Murati’s Thinking Machines Lab confronted the startup’s cofounder and former CTO, Barret Zoph, over an alleged relationship…

Drug discovery, the art of identifying new molecules to develop pharmaceuticals, is a notoriously time-consuming and difficult process. Traditional techniques,…

AI companies are clustering around healthcare and fast.  In just the past week, OpenAI bought health startup Torch, Anthropic launched Claude for…

OpenAI plans to start testing ads inside ChatGPT in the coming weeks, marking a significant shift for one of the…

On Thursday, OpenAI announced its investment in neurotech startup Merge Labs, cofounded by its CEO, billionaire Sam Altman. OpenAI will…

If someone ever makes an HBO Max series about the AI industry, the events of this week will make quite…

Just when you thought the circular deals couldn’t get any more circular, OpenAI has invested in CEO Sam Altman’s brain…

OpenAI, Google, and Anthropic announced specialised medical AI capabilities within days of each other this month, a clustering that suggests…

Former OpenAI exec Mira Murati’s startup, Thinking Machines Lab, is saying goodbye to two of its co-founders, both of whom…

Thinking Machines cofounders Barret Zoph and Luke Metz are leaving the fledgling AI lab and rejoining OpenAI, the ChatGPT-maker announced…

OpenAI announced Wednesday that it had reached a multi-year agreement with AI chipmaker Cerebras. The chipmaker will deliver 750 megawatts…

At the start of 2024, Anthropic, Google, Meta, and OpenAI were united against military use of their AI tools. But…

Dr. Sina Bari, a practicing surgeon and AI healthcare leader at data company iMerit, has seen firsthand how ChatGPT can…

Although public backlash against data centers has been intense over the past twelve months, all of the tech industry’s biggest…

Artificial intelligence is moving quickly into drug discovery as pharmaceutical and biotech companies look for ways to cut years off…